Withdrawal from 3‐Fluoroethamphetamine induces hyperactivity and depression‐like behaviors in male mice

Abstract

Abstract3‐Fluoroethamphetamine (3‐FEA) belongs to the amphetamine class of stimulant drugs and functions as a releasing agent for the monoamine neurotransmitters norepinephrine, dopamine, and serotonin. 3‐FEA acts on the central nervous system and elicits physical and mental side effects, such as euphoria, increased heart rate, and excitement. However, little is known about the withdrawal symptoms and behavioral changes induced by 3‐FEA administration. This study aimed to evaluate the short‐term consequences of 3‐FEA administration (twice a day, 7 days, i.p.; 1 and 10 mg/kg) in C57BL/6J mice (male, 7 weeks old) at three behavioral levels following 1–4 days of withdrawal. The evaluation included (1) withdrawal score, (2) hyperactivity (open field [OF], elevated plus maze [EPM], and cliff avoidance [CA] test), and (3) depression‐like behavior (forced‐swim test). In the withdrawal score test, withdrawal behavior increased in all 3‐FEA groups at 16 and 40 h after withdrawal. In the OF, EPM, and CA tests, the 3‐FEA administration group showed significant changes in terms of hyperactivity. In addition, in the forced‐swim test, both the 1 mg/kg and 10 mg/kg 3‐FEA groups showed increased immobility time. These findings indicate that 3‐FEA administration may lead to physical dependence, demonstrated by the withdrawal score increase and significant changes in hyperactivity and depression‐like behavior following repeated administration and drug cessation. In conclusion, this study reveals the adverse consequences of 3‐FEA administration and highlights the need for awareness raising and regulatory action to control the use of this new psychoactive substance.